CLINICS 2012;67(5):437-441 DOI:10.6061/clinics/2012(05)06 CLINICAL SCIENCE

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Assessment of knowledge and awareness about ovarian cancer and its risk factors among women in Jazan, Saudi Arabia: a cross-sectional study

  2025cites this paper
• The OvarianTag™ Biomarker Panel Emerges as a Prognostic Tool to Guide Clinical Decisions in Cisplatin-Based Treatment of Epithelial Ovarian Cancer

  2025cites this paper
• Exhausted and Senescent CD4+ T Cells in Peripheral Blood and Their Impact as a Biological Marker for the Diagnosis of Benign and Malignant Ovarian Tumors

  2025cites this paper
• Advancing ovarian cancer outcomes with CTGAN-enhanced hybrid machine learning approach

  2025cites this paper
• Detection of ovarian cancer using machine learning

  2025cites this paper
• An Overview of Integrative Approaches Combining ADE and LASSO for Feature Selection in Ovarian Cancer Detection

  2025cites this paper
• Monitoring and early warning of ovarian cancer using high-dimensional non-parametric EWMA control chart based on sliding window

  2025influential citation
• Diagnostic Accuracy of CA-125 Levels for Ovarian Tumor Patients with Suspected Malignancy

  2025influential citation
• Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer

  2024cites this paper
• Integrating Machine Learning Algorithms and Advanced Computing Technology Using an Ensemble Hybrid Classifier

  2024cites this paper
• Chistadenom mucinos gigant recidivat – caz clinic

  2023cites this paper
• Ovarian Cancer Prediction using Machine Learning

  2023cites this paper
• Improved Prediction of Ovarian Cancer Using Ensemble Classifier and Shaply Explainable AI

  2023cites this paper
• An Explainable Machine Learning Framework for the Accurate Diagnosis of Ovarian Cancer

  2023cites this paper
• Group penalized logistic regression differentiates between benign and malignant ovarian tumors

  2023cites this paper
• New Ultrasound Gynecological Reporting Data System (GIRADS) and Ovarian Reporting Data System (ORADS) for Distinguishing Adnexal Masses

  2023cites this paper
• Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer

  2023cites this paper
• Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis

  2023cites this paper
• Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.

  2022cites this paper
• Modified Risk of Ovarian Malignancy Algorithm and Risk of Malignancy Index in Predicting Epithelial Ovarian Cancer in Indonesian Population: A Single-centered Validation Study

  2022cites this paper
• The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis

  2022cites this paper
• Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram

  2022cites this paper
• Segmentation and classification of ovarian cancer based on conditional adversarial image to image translation approach

  2022cites this paper
• Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis

  2022cites this paper
• O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.

  2022cites this paper
• Early-Stage Detection of Ovarian Cancer Based on Clinical Data Using Machine Learning Approaches

  2022cites this paper
• Diagnostic protocols in oncology: workup and treatment planning. Part 2: Abbreviated MR protocol.

  2021cites this paper
• Using HE4, RMI, ROMA and CPH-I in the differential diagnosis of adnexal masses

  2021cites this paper
• ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

  2021cites this paper
• ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

  2021cites this paper
• A Comparative Study between 18F-FDG PET/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma

  2021cites this paper
• Can Nidogen-1 and Nidogen-2 improve our preoperative cancer detection rate?

  2021cites this paper
• Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature

  2021influential citation
• Ovarian Cancer Prediction Using PCA, K-PCA, ICA and Random Forest

  2021cites this paper
• Group Penalized Logistic Regressions Predict Ovarian Cancer ∗

  2021influential citation
• Consensus Statement on preoperative diagnosis of ovarian tumors

  2021cites this paper
• The role of inflammation biomarkers in differential diagnosis of pelvic tumours of ovarian origin: a single-centre observational study

  2021cites this paper
• CLINICAL APPLICATION OF NOVEL CIRCULATORY BIOMARKERS IN EPITHELIAL OVARIAN CANCER

  2020cites this paper
• The Role of HE4 in diagnosis and preoperative staging of epithelial ovarian cancer

  2020cites this paper
• Adnexal mass: diagnosis and management

  2020cites this paper
• Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early-stage ovarian cancer according to imaging tumor subtypes.

  2020cites this paper
• Using machine learning to predict ovarian cancer

  2020cites this paper
• The Efficacy of HE4 and ROMA in Prediction of Ovarian Malignancy in Comparison to CA-125 and RMI

  2020cites this paper
• Management of Ovarian Cystic Tumor: Diagnosis, Management, and Its Follow-Up-Case Presentation of Three Patients and Literature Review

  2020cites this paper
• Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses.

  2020cites this paper
• ANDALAS OBSTETRICS AND GYNECOLOGY JOURNAL

  2020cites this paper
• Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses

  2020cites this paper
• SÍNDROME DE MEIGS SECUNDARIO A TUMOR DE CÉLULAS DE LA GRANULOSA : REPORTE DE CASO

  2020cites this paper
• Current Strategies and Recent Advances in Gynaecological Oncology Imaging

  2020cites this paper
• Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

  2019cites this paper
• The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers.

  2019cites this paper
• Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

  2019cites this paper
• The role of human epididymis protein 4 as a biomarker in gynecologic malignancies.

  2019cites this paper
• Ovarian Cancer Immature Teratoma Type in Pregnancy: Management and Feto-Maternal Outcomes

  2019cites this paper
• Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer.

  2019cites this paper
• Screening for Ovarian Cancer

  2019cites this paper
• Risk of Ovarian Malignancy Algorithm versus Risk Malignancy Index-I for Preoperative Assessment of Adnexal Masses: A Systematic Review and Meta-Analysis

  2019cites this paper
• Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass

  2019cites this paper
• Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

  2018cites this paper
• Diagnostic Accuracy of Risk of Ovarian Malignancy Algorithm (ROMA) in Post-Menopausal Patients with Ovarian Mass.

  2018cites this paper
• PATIENT-CENTERED RISK ASSESSMENT FOR OVARIAN CANCER : INDIVIDUALIZING

  2018cites this paper
• Evaluation of the risk of malignancy index in preoperative diagnosis of ovarian masses

  2018cites this paper
• The Diagnostic Value of Serum CEA, CA-125, and ROMA Index in Low-Grade Serous Ovarian Cancer

  2018cites this paper
• COMPARATIVE CHARACTERISTICS OF THE AVAILABLE LABORATORY TESTS AND THEIR COMBINATIONS USED IN DIFFERENTIAL DIAGNOSIS OF OVARIAN NEOPLASMS

  2018influential citation
• A Comparative Study of RMI and ROMA in Women Presenting with an Adnexal Mass

  2018cites this paper
• Comparison of Serum Human Epididymis Protein (HE4), Carbohydrate Antigen 125(CA125) and Risk of Ovarian Malignancy Algorithm (ROMA) as Markers in Ovarian Cancer: A Systematic Review and a Meta-analysis

  2018cites this paper
• RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study

  2018cites this paper
• Utilidad de la Proteína Epididimal Humana 4 (HE4) en la detección de Cáncer de ovario.

  2018cites this paper
• Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.

  2018cites this paper
• Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam

  2018influential citation
• Evaluation in the predictive value of serum human epididymal protein 4 (HE4), cancer antigen 125 (CA 125) and a combination of both in detecting ovarian malignancy

  2018cites this paper
• [Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].

  2017cites this paper
• Ovarian Cancer and Resistance to Therapies: Clinical and Laboratory Perspectives

  2017cites this paper
• Diagnostic value of urinary-to-serum human epididymis protein 4 ratio in ovarian cancer.

  2017cites this paper
• Performance of ROMA based on Architect CA 125 II and HE4 values in Chinese women presenting with a pelvic mass: A multicenter prospective study.

  2017cites this paper
• Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.

  2017cites this paper
• Clinical applications in gynaecological cancer

  2017influential citation
• A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer an international multicenter study of women with an ovarian mass

  2017cites this paper
• HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

  2017cites this paper
• A new strategy for calculating the risk of ovarian malignancy algorithm (ROMA)

  2017cites this paper
• Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

  2017cites this paper
• The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review

  2017cites this paper
• Early Diagnosis of Gynecological Cancers in Ladies with Review of Literature

  2017cites this paper
• An Unusual Evolution of Krukenberg Tumour: A Case Report.

  2016cites this paper
• The preoperative predictors of optimal cytoreductive surgery in women with advanced epithelial ovarian cancer

  2016cites this paper
• Comparing the Copenhagen Index (CPH-I) and Risk of Ovarian Malignancy Algorithm (ROMA): Two equivalent ways to differentiate malignant from benign ovarian tumors before surgery?

  2016cites this paper
• Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125

  2016influential citation
• Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass.

  2016cites this paper
• Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China.

  2016cites this paper
• The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer

  2016cites this paper
• Novel Methods for Prevention and Early Diagnosis of Ovarian and Endometrial Cancers

  2016cites this paper
• Tratamiento de los quistes de ovario

  2016cites this paper
• A Comparative Study of Serum Levels of HE4 and CA125 in Women with Ovarian Masses

  2016cites this paper
• ROMA, an algorithm for ovarian cancer.

  2015cites this paper
• A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.

  2015cites this paper
• Role of Risk Malignancy Index in Predicting Ovarian Malignancy and its Correlation with Histopathological Report

  2015cites this paper
• Role of HE4 in the Management of Ovarian Cancer

  2015cites this paper
• Diagnostic Value of the Risk of Malignancy Index (RMI) for Detection of Pelvic Malignancies Compared with Pathology

  2015cites this paper
• Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies

  2015cites this paper
• DIAGNOSTIC VALUE OF HE4, CA125 AND RISK OF OVARIAN MALIGNANCY ALGORITHM IN DETECTING OVARIAN CANCER

  2015cites this paper